Spire Healthcare Group (LON:SPI) Trading 8.8% Higher - Should You Buy?

Key Points

• Spire Healthcare Group's stock experienced an 8.8% increase during trading, reaching a last traded price of GBX 235.50 ($3.19), with a significant surge in trading volume at over 9 million shares.
• Analyst ratings for Spire Healthcare are generally positive, with three analysts giving a Buy rating and a consensus price target of GBX 294.33, despite JPMorgan decreasing their target to GBX 303.
• The company reported an EPS of GBX 4.10 for the last quarter, with analysts forecasting an annual EPS of approximately 15.66, indicating potential growth for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 8.8% on Friday . The stock traded as high as GBX 237.50 ($3.20) and last traded at GBX 235.50 ($3.17). 9,013,502 shares changed hands during trading, an increase of 515% from the average session volume of 1,465,043 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several research firms have weighed in on SPI. JPMorgan Chase & Co. cut their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Berenberg Bank reiterated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Trading Down 4.4%

The firm's 50-day simple moving average is GBX 218.75 and its 200 day simple moving average is GBX 203.55. The stock has a market capitalization of £949.70 million, a P/E ratio of 5,131.02, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Equities research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.